amount of intracellular apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC). The reduction of ASC was associated with enhanced autophagosome formation and autophagic flux. Inhibition of autophagy prevented the CoPP-induced depletion of ASC, implying that the depletion was caused by increased autophagy. Our data indicate that hemin functions as an endogenous negative regulator of the NLRP3 inflammasome. The inhibition is mediated via enhanced autophagy that results in increased degradation of ASC. This regulatory mechanism may provide a novel approach for the treatment of inflammasomerelated diseases.
responsible for the degradation of damaged or senescent erythrocytes, they are central cells for heme and hemin catabolism and iron homeostasis [1] . In response to danger signals, they secrete a myriad of proinflammatory cytokines. Of these, interleukin (IL)-1β and IL-18 are synthesized as precursor proteins, which need to be processed to their mature secreted forms by cytosolic multiprotein complexes, called inflammasomes [2] . Inflammasomes are activated by a variety of endogenous and exogenous activators, such as adenosine triphosphate (ATP) released from damaged cells, cholesterol and urate crystals as well as bacterial toxins [3] [4] [5] . The most studied inflammasome is the NLRP3 (nucleotide-binding domain and leucine-rich repeat containing family, pyrin domain containing 3). The NLRP3 inflammasome comprises the pattern recognition receptor NLRP3 and the adaptor protein ASC (apoptosis-associated speck-like protein containing a caspase-recruitment domain), which, upon activation, oligomerizes and recruits procaspase-1 into the inflammasome complex [6] . The oligomerized ASC can be visualized as a large cytosolic 'ASC speck' [6] . Assembly of the inflammasome complex results in the autocleavage-mediated activation of caspase-1, thereby rendering it capable of cleaving pro-IL-1β and pro-IL-18 into their mature secreted forms [2] .
The activation of the NLRP3 inflammasome requires 2 separate signals. A priming signal, mediated by the activation of TLRs or cytokine receptors, induces the upregulation of the NLRP3 protein as well as the expression of pro-IL-1β [7] . The second signal is required for the induction of inflammasome assembly and the activation of the inflammasome complex. The exact mechanisms of such activation by the structurally and chemically diverse agonists of the NLRP3 inflammasome are currently not known, but the process has been suggested to involve potassium efflux, the production of reactive oxygen species (ROS), mitochondrial dysfunction and lysosomal destabilization that results in the release of cathepsin B [2] .
Gain-of-function mutations of NLRP3, which result in excessive production of IL-1β, underlie the pathogenesis of cryopyrin-associated autoinflammatory diseases, such as Muckle-Wells syndrome [3] . A role for enhanced NLRP3 inflammasome activity has also been implicated in the pathogenesis of some common disorders, such as gout, in which the urate crystals activate the NLRP3 inflammasome [8] , and atherosclerosis [4, 5] . Thus, it is obvious that stringent control mechanisms of inflammasome activation are needed. In contrast to the myriad of described activators of the NLRP3 inflammasome, much less is known about its negative regulation. Endogenous proteins, such as card-and pyrin-only proteins have been shown to inhibit the assembly of the NLRP3 inflammasome [9] . Several posttranslational modifications of inflammasome components also inhibit the assembly and activation of the NLRP3 inflammasome [10] .
Macroautophagy, hereafter referred to as autophagy, is a vesicular trafficking process that targets damaged or superfluous cellular proteins and organelles for degradation [11] . Recently, autophagy was also shown to be capable of downmodulating the NLRP3 inflammasome activation and secretion of IL-1β [12] [13] [14] . Ubiquitinated inflammasome components are directed to autophagosomes by sequestosome 1 (SQSTM1) [13] and, subsequently, the fusion of autophagosomes with lysosomes results in the degradation of inflammasome components by lysosomal hydrolases [11] . Furthermore, damaged mitochondria, which are capable of promoting NLRP3 inflammasome activation, are constantly disposed of by autophagy [14] . However, the relationship between autophagy and the inflammasome-induced secretion of IL-1β is complex. For example, despite the role of autophagy as a negative regulator of inflammasome activation, it has also been shown to be required for the secretion of IL-1β [15] .
In this study, we identified a novel negative regulatory mechanism of the activation of the NLRP3 inflammasome. We show that hemin and its derivative, cobalt protoporphyrin (CoPP), strongly inhibit the secretion of IL-1β by depleting the intracellular levels of ASC, thus abolishing the formation of ASC specks. Hemin and CoPP reduce the amount of ASC by increasing the autophagy, and thereby direct ASC for degradation in autophagosomes.
Materials and Methods

Reagents
Lipopolysaccharide (LPS) from the E. coli 0111:B4 strain (UltraPure LPS) from InvivoGen (San Diego, Calif., USA) was used for the priming of mouse macrophages and LPS from Sigma (Saint Louis, Mo., USA) was used for the priming of human primary macrophages and THP-1 macrophages. CoPP, hemin and bilirubin were from Sigma and tin mesoporphyrin (SnMP) was from Santa Cruz (Dallas, Tex., USA). CoPP (150 m M ) and bilirubin (5 m M ) were dissolved in DMSO, while hemin (5 m M ) and SnMP (10 m M ) were dissolved in 0.1 M NaOH, neutralized and sterile filtered. Tricarbonyldichlororuthenium (II) dimer was from Sigma. The water-soluble carbon monoxide-releasing molecule tricarbonylchloro(glycinato)ruthenium(II) (CORM-3) was synthesized as previously described by Clark et al. [16] , and stored at -20 ° C as a lyophilisate. Nigericin sodium salt was from Sigma. Recombinant human apo-serum amyloid A (SAA) (isotype 1α), with an endotoxin level of <1 EU/μg protein, as determined by the manufacturer, was from Peprotech (Princeton, N.J., USA). Mono-sodium urate (MSU) crystals were prepared from uric acid (Sigma) as previously described [17] , and stored at -20 ° C. The endotoxin level of the crystals was found to be below the detection limit (<0.03 EU/ml) in the Pyrogent gel clot LAL assay (Lonza, Walkersville, Md., USA).
Animals
All animal experiments were conducted in conformity with Finnish regulations and the protocols were approved by The National Animal Experiment Board (permission No. ESAVI/ 4690/04.10.07/2015). All mice were housed with 5-6 mice per cage in conditions controlled for light/dark cycle, temperature and humidity. The mice had unlimited access to drinking water and food (standard chow: Teklad Global 16% protein rodent diet, Harlan Laboratories, Madison, Wis., USA or Altromin 1314 FORTI, breeding diet rats/mice, Lage, Germany). Wild-type (WT) C57BL/6J mice, used for in vivo experiments, were obtained from Harlan Laboratories, Venray, The Netherlands. HMOX1 fl/-mice (on a mixed C57BL/6.129/Sv background) were obtained from Biomedical Sciences Research Center 'Alexander Fleming' (Vari, Greece) [18] . HMOX1 fl/-mice were further inbred to generate HMOX1 fl/fl mice. Myeloid cell-specific ablation of Hmox1 was generated as follows: HMOX1 fl/fl mice were crossed with LysMCre +/+ mice (Jackson Laboratories, Bar Harbor, Maine, USA; B6.129P2-Lyz2 tm1(cre)Ifo /J, the mouse strain is backcrossed to C57BL/6 for at least 6 generations) that express cre-deleter in the cells of myeloid cell lineage [19] . The LysMCre +/-HMOX1 fl/-mice obtained were backcrossed with HMOX1 fl/fl mice to generate LysMCre +/-HMOX1 fl/fl mice. Thioglycollate-elicited peritoneal macrophages (TEPMs) were collected from LysMCre +/-HMOX1 fl/fl and littermate controls LysMCre -/-HMOX1 fl/fl . Primer pairs used in genotyping are listed in table 1 .
Cell Cultures
Human Primary Macrophages Human mononuclear cells were isolated by density gradient centrifugation (800 g for 30 min) in Ficoll-Paque PLUS (GE Healthcare Life Sciences, Uppsala, Sweden) from fresh buffy coats supplied by the Finnish Red Cross Blood Service (Helsinki, Finland). Buffy coats were obtained from healthy blood donors, after obtaining informed consent. The buffy coats were byproducts of the preparation of blood products for clinical use. The use of buffy coats in monocyte isolation was approved by the Finnish Red Cross Blood Service, Helsinki, Finland. Monocytes were allowed to adhere on cell culture wells, and nonadherent mononuclear cells were removed by washing with PBS w/o Ca 2+ and Mg
2+
. The obtained monocytes were differentiated into macrophages using recombinant granulocyte macrophage colony-stimulating factor (GM-CSF, 10 ng/ml; Nordic Biosite, Täby, Sweden) in macrophage serum-free medium (Gibco/Life Technologies, Carlsbad, Calif., USA), supplemented with 100 U/ml penicillin and 100 μg/ ml streptomycin, as previously described [20] . Each experiment with primary human macrophages was performed using macrophages derived from at least 4 donors.
Human Monocytic Leukemia Cell Line Macrophages
The human monocytic leukemia cell line (THP-1) was purchased from the American Type Culture Collection (ATCC, Catalog No. TIB-202, Manassas, Va., USA). Cells were maintained in RPMI 1640 supplemented with 2 m M L -glutamine, 10% fetal bovine serum, 25 m M HEPES, 100 U/ml penicillin and 100 μg/ml streptomycin (all from Lonza). Monocyte-to-macrophage differentiation of THP-1 cells was induced by PMA (100 n M , 72 h) (Sigma). In the experiments, only PMA-differentiated THP-1 cells, i.e. THP-1 macrophages, were used.
Mouse Macrophages
Femoral and tibial bone marrow cells of WT mice were differentiated into bone marrow-derived macrophages (BMDMs) in the presence of 50 ng/ml of macrophage colony-stimulating factor (M-CSF, Nordic Biosite) in RPMI 1640 supplemented with 2 m M Lglutamine, 10% fetal bovine serum, 25 m M HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin and β-mercaptoethanol (Sigma) for 7 days. For the collection of BMDMs, the mice were terminally anesthetized with isofluorane, and euthanasia was assured by cervical dislocation. Bone marrow was flushed with PBS, and erythrocytes were removed using red blood cell lysing buffer (Sigma). TEPMs were harvested from the peritoneal fluid 3 days after the injection of thioglycollate medium (2 ml) into the peritoneal cavity. The cells were plated in cell culture wells and allowed to adhere in the presence or absence of LPS (0.01 μg/ml, 3 h) as a priming factor, after which they were washed and used for the experiments.
MSU Peritonitis
WT female C57BL/6J (aged 8-13 weeks) mice were used for in vivo experiments. Before the experiments, the mice received buprenorphine (0.1 mg/kg) subcutaneously for analgesia. Prior to the induction of peritonitis, they received intraperitoneal (i.p.) injection of CoPP (25 mg/kg in PBS, 300 μl/mouse) or PBS (300 μl/ mouse), followed by an i.p. injection of MSU crystals (3 mg in PBS, 300 μl/mouse) or PBS (300 μl/mouse) 1 h later. Peritonitis was allowed to develop for 20 h, after which the mice were terminally anesthetized by isoflurane, fully exsanguinated by cardiac puncture, and the peritoneal cavity was lavaged with 2 ml of 0.1% BSA in PBS. The peritoneal fluid was centrifuged at 200 g for 5 min and the total cell counts were determined by using a Bürker chamber. 
Inflammasome Activation in Cultured Macrophages
Briefly, to activate the NLRP3 inflammasome, macrophages were first primed with the TLR4 agonist LPS for 3 h. Different final concentrations of LPS were used: human primary macrophages and THP-1 macrophages (1 μg/ml), and mouse macrophages (0.01 μg/ml). After priming, the cells were washed twice and incubated in the presence of the indicated concentrations of CoPP, hemin, CORM-3 or bilirubin (incubation times are given below). CoPP, hemin, CORM-3 and bilirubin were present during inflammasome activation.
Activation of the NLRP3 Inflammasome After LPS-primed macrophages were incubated for 3 h in the presence of the indicated concentrations of CoPP or hemin, ATP (5 m M , 30 min) or nigericin (4 μ M , 1 h) was added. To examine the effect of carbon monoxide, the LPS-primed human primary macrophages or THP-1 macrophages were incubated for 1 h in the presence of the indicated concentrations of CORM-3, after which ATP was added (5 m M , 30 min). The LPS-primed THP-1 macrophages were incubated in the presence of the indicated concentrations of bilirubin (20 min) and activated with ATP (5 mM , 30 min). SAA was used for both the priming and activation of the NLRP3 inflammasome [21] . Macrophages were incubated in the presence of CoPP or hemin for 1 h prior to the addition of SAA (THP-1 macrophage activation: 3 μg/ml, 5 h; BMDM activation: 2 μg/ml, 18 h; human primary macrophage activation: 3 μg/ml, 18 h). LPS-primed BMDMs were incubated in the presence of CoPP or hemin for 1 h prior to the addition of MSU crystals (250 μg/ml, 18 h). The enzymatic inhibitor of heme oxygenase-1 (HO-1), SnMP (5 μ M ), was administered to THP-1 macrophages 3 h prior to CoPP, and an inhibitor of autophagy, 3-methyl adenine (3-MA, 5 m M ; Calbiochem, San Diego, Calif., USA), was added to the THP-1 macrophages 23 h prior to CoPP.
Measurement of Cell Death
Trypan blue stain (0.2% w/v, 2 min) was routinely used to evaluate cell death. Cytotoxicity detection kit (Roche, Mannheim, Germany) based on the determination of lactate dehydrogenase (LDH) release was used according to the manufacturer´s protocol.
ELISA Assays
IL-1β and IL-18 concentrations in cell culture medium and IL-1β concentration from mouse peritoneal lavage were determined by using commercial sandwich ELISA assays (IL-1β assay by R&D Systems, Minneapolis, Minn., USA; IL-18 assay by Medical and Biological Laboratories, Nagoya Aichi, Japan) according to the manufacturer's instructions.
Quantitative Real-Time RT-PCR
The quantitative real-time RT-PCR protocol used has been described previously [22] . The gene-specific primers and probes are given in table 2 .
Immunoblot Analysis
Cell culture media were concentrated using Vivaspin 6 centrifugal concentrator with a 5-kDa cut-off (Sartorius, Göttingen, Germany). Adherent cells were collected and lysed in buffer containing 250 m M sucrose and 1 m M EDTA and supplemented with 1× protease inhibitor cocktail, pH 7.0 (Roche, Mannheim, Germany). Proteins of cell lysates or concentrated medium samples were resolved by SDS-PAGE, and transferred to a PVDF membrane (Millipore, Billerica, Mass., USA). PVDF membranes were incubated o/n at 4 ° C with antibodies raised against human IL-1β (proform detection: Santa Cruz Biotechnology; mature form detection: Cell Signaling, Danvers, Mass., USA), caspase-1 (AdipoGen, San Diego, Calif., USA), HO-1 (Santa Cruz Biotechnology), SQSTM1 (Santa Cruz Biotechnology), light chain 3 (LC3; Novus Biologicals, Littleton, Colo., USA), ASC (MBL international, Wo- Human GAPDH F 5′-CCACATCGCTCAGACACCAT-3′ our laboratory GAPDH R 5′-GGCAACAATATCCACTTTACCAGAG-3′ our laboratory GAPDH fluorogenic probe 5′-FAM-CCAATACGACCAAATCCGTTGACTCC-BHQ1-3′ our laboratory HMOX1 F 5′-TCCTGCTCAACATCCAGCTC-3′ our laboratory HMOX1 R 5′-GGGCAGAATCTTGCACTTTG-3′ our laboratory IL1B F 5′-TTACAGTGGCAATGAGGATGAC-3′ our laboratory IL1B R 5′-GTCGGAGATTCGTAGCTGGAT-3′ our laboratory IL1B fluorogenic probe 5′-FAM-AACAGATGAAGTGCTCCTTCCAGGACC-BHQ1-3′ our laboratory NLRP3 F 5′-GGAGAGACCTTTATGAGAAAGCAA-3′ our laboratory NLRP3 R 5′-GCTGTCTTCCTGGCATATCACA-3′ our laboratory NLRP3 fluorogenic probe 5′-FAM-ACGTGCATTATCTGAACCCCACTTCGG-BHQ1-3′ our laboratory
Applied Biosystems burn, Mass., USA) and β-actin (Abcam, Cambridge, UK). HRPconjugated polyclonal goat-anti-mouse and rabbit-anti-goat antibodies (Dako, Glostrup, Denmark) were used as secondary antibodies. The band intensities were quantified by Bio-Rad ChemiDoc MP imaging system (USA). The band intensities were normalized to the intensity of β-actin bands, except for the intensity of LC3-II bands, which were compared to the intensity of LC3-I bands by calculating the LC3-II/LC3-I ratio.
Cathepsin B/L activity measurement
Nigericin-and SAA-induced release of cathepsin B from lysosomes [21, 24] was assessed as previously described [22] . Briefly, LPS-primed THP-1 macrophages were incubated in the presence of 2.5 μ M CoPP for 3 h, after which nigericin was added (4 μ M , 1 h). When SAA was used as the activator, THP-1 macrophages were incubated in the presence of CoPP (2.5 μ M , 1 h) and then activated with SAA (3 μg/ml, 5 h). Cathepsin B/L-dependent hydrolysis of the fluorogenic substrate Z-Phe-Arg-AMC (Enzo Life Sciences, Farmingdale, N.Y., USA) (40 μ M ) in the medium was measured (excitation at 355 nm, emission at 486 nm) after 1 h of incubation at 37 ° C.
Immunofluorescence Microscopy ASC speck detection was performed as previously described [22] . Briefly, THP-1 macrophages were incubated in the presence of CoPP (2.5 μ M ) or hemin (5 μ M ) for 3 h before the addition of the NLRP3 inflammasome activator, nigericin (4 μ M , 1 h). PFAfixed cells were stained with anti-ASC antibody (MBL International), goat-anti-mouse IgG1 Alexa Fluor 488 (Invitrogen, Eugene, Oreg., USA) was used as secondary antibody and the nuclei were stained with DAPI. The speck formation was quantified by epifluorescence microscopy. The number of specks/field were divided by the number of cells/field, and expressed as percentages; 10 different fields (on average 200 cells/field) were counted in each of the 4 experiments.
For the SQSTM1/ASC double-immunofluorescence staining, THP-1 macrophages were incubated in the presence of CoPP (5 μ M ) for 2 or 4 h. PFA-fixed cells were stained with antibodies for ASC (Adipogen, San Diego, Calif., USA) and SQSTM1 (Santa Cruz Biotechnology). Goat-anti-rabbit IgG (H+L) Alexa Fluor 594 for ASC and goat-anti-mouse IgG1 Alexa Fluor 488 for SQSTM1 (both from Invitrogen) were used as secondary antibodies. The nuclei were stained with DAPI.
Measurement by Inductively Coupled Plasma Mass
Spectrometry THP-1 macrophages were incubated in the presence of CoPP (2.5 μ M , 3 h), after which the NLRP3 inflammasome was activated with nigericin (4 μ M , 1 h). Analysis of intracellular potassium concentration was performed by inductively coupled plasma mass spectrometry (ICP-MS) as previously described [22] . Briefly, THP-1 macrophages from 6 parallel wells were lysed in 70% nitric acid (Romil-SpA, Cambridge, UK), and the potassium concentration was determined according to ISO 17294-2 [25] in helium mode (Agilent 7500 ce/cx ICP-MS, Alpharetta, Ga., USA). Analyses were performed at the Department of Geosciences and Geography, University of Helsinki. Elemental recovery of 101% was measured using the National Institute of Standards and Technology standard as the reference (NIST-1577C, Gaithersburg, Md., USA).
ROS Generation Assays
To analyze cytosolic ROS formation, THP-1 macrophages were incubated in the presence of hemin (5 μ M ) or CoPP (5 μ M ) for 1 or 3 h, after which the cells were stimulated with nigericin or left nonstimulated (4 μ M , 1 h). Before the measurement, the cells were washed and incubated for 30 min at 37 ° C in 5% CO 2 in PBS with Ca 2+ and Mg 2+ containing 50 μ M dihydrorhodamine 123 (DHR 123) (Sigma), hemin or CoPP, and nigericin. The cells were lysed in 200 μl of 1% TritonX and the fluorescence was measured immediately with a plate reader (Hidex Plate Chameleon 5, Turku, Finland), with excitation at 500 nm and emission at 536 nm.
To assess the accumulation of mitochondrial ROS, THP-1 macrophages were incubated in the presence of hemin (5 μ 
Statistical Analysis
Statistical analyses were performed using GraphPad Prism v6 for Windows. Statistical differences between groups were identified using one-way analysis of variance (ANOVA) followed by the Tukey, Dunnett or Holm-Sidak multiple comparisons tests when appropriate. Nonnormally distributed data was log 2 -transformed before statistical testing, and is indicated in the figure legends. Data are presented as means ± standard deviation (SD) of data from ≥ 3 independent experiments. 
Results
Hemin and CoPP Reduce the Secretion of IL-1β by Mouse and Human Macrophages
Mouse BMDMs, human primary macrophages or THP-1 macrophages were incubated in the presence of hemin or CoPP, after which the NLRP3 inflammasome was activated with ATP, SAA, MSU crystals or nigericin. As demonstrated in figure 1 , the secretion of IL-1β, induced by different NLRP3 inflammasome activators, was significantly reduced in the presence of hemin or CoPP, in both mouse ( fig. 1 a-d) and human ( fig. 1 e, f) macrophages. A similar inhibitory effect was also observed in the THP-1 macrophages ( fig. 1 g) . It should be noted that THP-1 macrophages were more sensitive to the inhibitory effect of CoPP and hemin and mouse BMDMs to the effect of CoPP when compared to human primary macrophages.
The IL-1β ELISA results were confirmed by Western blot studies, which showed reduced secretion of the mature form (17 kDa) of IL-1β ( fig. 2 a, b ; online suppl. fig. 1A -C; for all online suppl. material, see www. karger.com/doi/10.1159/000448894) and processed active form (20 kDa) of caspase-1 ( fig. 2 c, d ; online suppl. fig. 1D-F) in the THP-1 macrophages in the presence of hemin or CoPP. The incubation of the cells in the presence of CoPP or hemin had no effect on cell viability (online suppl. fig. 1G, H) . Inhibition of the NLRP3 inflammasome by CoPP was also evident in vivo ( fig. 2 e) . Thus, i.p. injection of CoPP 1 h prior to induction of peritonitis by i.p. administration of MSU crystals significantly reduced the secretion of IL-1β into the peritoneal cavity. Pretreatment with CoPP also tended to diminish leukocyte influx into the peritoneal cavity, but the reduction was not statistically significant ( fig. 2 f) .
Hemin and CoPP Do Not Interfere with the Priming of the NLRP3 Inflammasome
Before NLRP3 inflammasome can be activated, a separate priming step is required during which the expression of NLRP3 receptor and the proform of IL-1β are induced [7] . So next, we studied whether hemin and CoPP reduced IL-1β secretion by inhibiting the priming step. For this purpose, human primary macrophages were primed via the activation of TLR4 with LPS and were then treated with hemin or CoPP. Treatment with both compounds did not reduce the expression of IL1B or NLRP3 ( fig. 3 a,  b) . Likewise, no reduction was observed in the expression of IL1B or NLRP3 in THP-1 macrophages (online suppl. fig. 1I, J) . On the contrary, CoPP and hemin rather enhanced the expression of IL1B in human primary macrophages. The LPS-induced expression of NLRP3 is known to be transient [5, 7] and thus, at the time point of the measurement, the expression had already returned to baseline. These results are in agreement with the results obtained from Western blots of cell lysates from THP-1 macrophages, showing that neither CoPP nor hemin had any significant effect on the intracellular protein levels of procaspase-1 or pro-IL-1β ( fig. 3 c, d ; online suppl. fig. 2A-F) . However, a slight reduction in protein levels of intracellular NLRP3 was observed in the CoPP-treated THP-1 macrophages. Furthermore, hemin and CoPP also reduced the secretion of the mature IL-18 in the THP-1 macrophages ( fig. 3 e) , the proform of which is constitutively expressed in these cells, and so priming is not required for its secretion [26] . The data above indicate that the inhibition of IL-1β secretion by hemin or CoPP is not caused by the inhibition of the priming step, but instead by that of NLRP3 inflammasome activation.
CoPP Inhibits Release of Cathepsin B and Production of Mitochondrial ROS but Has No Effect on Potassium Efflux
The intracellular events upstream of NLRP3 inflammasome activation include potassium efflux, leakage of lysosomal protease cathepsin B and ROS formation. The effect of CoPP on the potassium efflux was assessed by measuring the concentration of cellular potassium using ICP-MS. Activation of the NLRP3 inflammasome in THP-1 macrophages with nigericin significantly decreased the intracellular potassium concentration in the treated cells ( fig. 4 a) . However, preincubation of the cells in the presence of CoPP had no impact on the intracellular potassium concentration, in either the nigericin-activated or nonactivated THP-1 macrophages.
Release of cathepsin B from intact lysosomes during nigericin-or SAA-induced activation is closely associated with the activation of the NLRP3 inflammasome [21, 24] . The release of lysosomal cathepsins into cell culture medium has been shown to accompany the secretion of mature IL-1β [15] . Both nigericin and SAA induced a robust release of enzymatically active cathepsin B into the cell culture medium from the THP-1 macrophages, which was significantly inhibited by CoPP ( fig. 4 b, c) . The mechanisms needed for the secretion of IL-1β are not explicitly known, but autophagy-driven secretion of IL-1β, during which IL-1β is released from autophagosomal compartments, has been suggested [15] . It is therefore possible that the reduced release of active cathepsin B from CoPPtreated cells reflected the diminished secretion of IL-1β and the inflammasome components from the autolysosomes rather than the impairment of cathepsin B-dependent NLRP3 inflammasome activation.
Mitochondrial ROS has been implicated in the activation of the NLRP3 inflammasome [14] . To assess the effect of hemin and CoPP on mitochondrial superoxide generation, a fluorogenic probe (mitoSOX), which specifically detects mitochondrial superoxide, was used. Hemin and CoPP alone had no effect on the generation of mitochondrial ROS compared to the nontreated cells, but inflammasome activation by nigericin induced a robust accumulation of mitochondrial ROS ( fig. 4 d, e) . Importantly, the incubation of cells with hemin or CoPP prior to the inflammasome activation reduced the accumulation of mitochondrial ROS.
Heme and hemin are pro-oxidant molecules that have been shown to induce ROS formation by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in macrophages [27] . To determine the effect of hemin and CoPP on cytosolic ROS formation, we assessed the fluorescence intensity of DHR 123 staining in nonstimulated and nigericin-stimulated THP-1 macrophages. DHR123 detects cytosolic ROS species generated via NADPH oxidase activation, among other sources. In both stimulated and nonstimulated THP-1 macrophages, the generation of ROS was increased by hemin and, to a lesser extent, with CoPP when compared to nontreated cells ( fig. 4 f) . Taken together, the reduced accumulation of mitochondrial ROS by hemin and CoPP could have contributed to their inhibitory effect on nigericin-induced NLRP3 in- flammasome activation whereas their effect on NADPH oxidase-generated ROS is a less probable mechanism for the inhibition.
Inhibition of NLRP3 Inflammasome by Hemin and CoPP Is Partially Dependent on Heme Oxygenase-1
Since heme/hemin and CoPP are well-established inducers of the heme-catabolizing antioxidant enzyme HO-1 [28] , we next studied whether the inhibitory effect of hemin and CoPP on NLRP3 inflammasome activation could be mediated via the induction of HO-1. Hemin and CoPP induced HO-1 protein expression during the first 4 h after their addition to the THP-1 macrophages ( fig. 5 a; online suppl. fig. 2G ), and a more robust expression was observed later at the 8-hour and 16-hour time points. Stannous mesoporphyrin (SnMP), a competitive inhibitor of HO-1 enzymatic activity [28] , strongly reversed the CoPP-induced inhibition of IL-1β secretion ( fig. 5 b) . Furthermore, of the products of heme/hemin degradation, carbon monoxide, but not bilirubin, attenuated the secretion of IL-1β ( fig. 5 c; online suppl. fig. 2H, I ).
The role of HO-1 as an endogenous inhibitor of the NLRP3 inflammasome was further studied in TEPMs obtained from mice carrying a myeloid cell line-targeted deletion of Hmox1 (LysMCre +/-HMOX1 fl/fl ). A trend of reduced Hmox1 expression was observed in the HO-1-de- ), supporting the hypothesis that HO-1 can function as an endogenous regulator of the NLRP3 inflammasome (online suppl. fig. 2K ).
The inhibitory effect of CoPP and hemin on the secretion of IL-1β by the HO-1-deficient TEPMs was comparable with the inhibition observed in the TEPMs derived from the WT littermates (online suppl. fig. 2K ). These results argue against the hypothesis proposing a role for CoPP-and hemin-induced HO-1 as a mechanism of NLRP3 inflammasome inhibition. However, it should be noted that CoPP and hemin treatment was able to increase Hmox1 expression, also in the HO-1-deficient TEPMs (online suppl. fig. 2J ). Altogether, the data above suggest that induction of HO-1 may contribute to the inhibitory effect of hemin and CoPP. Nevertheless, due to the limitations of the HO-1-deficient mouse model, i.e. the deletion of Hmox1 in TEPMs was not complete, such a role for HO-1 could not be ascertained.
Hemin and CoPP Inhibit Inflammasome Complex Formation by Depleting Intracellular ASC
To further elucidate the mechanism by which CoPP and hemin inhibit inflammasome function, we studied their effect on the assembly of the NLRP3 inflammasome. The adaptor protein ASC is an obligatory mediator of molecular interactions between the receptor protein and procaspase-1 of the NLRP3 inflammasome [3] . Upon inflammasome activation, ASC-dimers aggregate and form large structures called ASC specks or ASC foci, typically 1 speck/cell [6] . Nigericin induced a robust formation of ASC specks in THP-1 macrophages ( fig. 6 a, b) . The incubation of THP-1 macrophages in the presence of hemin or CoPP prior to the nigericin-induced activation of the NLRP3 inflammasome not only abolished the speck formation but also dramatically reduced the level of ASC staining in the cytoplasm ( fig. 6 a) . The reduction of the amount of intracellular ASC was further confirmed by Western blots of the cell lysates, which demonstrated that incubation of THP-1 macrophages in the presence of CoPP or hemin reduced the amount of ASC both in nonactivated and nigericin-activated cells ( fig. 6 c, d ; online suppl. fig. 3A , B).
A relatively low mRNA expression of endogenous ASC (on average Ct 26.9) was detected in THP-1 macrophages, and it could not be significantly induced by nigericin. Moreover, the treatment of THP-1 macrophages with CoPP or hemin had no significant impact on the expression of ASC mRNA (online suppl. fig. 3C ). A robust release of ASC protein in the cell culture medium was observed in nigericin-activated THP-1 macrophages ( fig. 6 e, f; online suppl. fig. 3D, E) . However, the nigericin-induced release of ASC was significantly diminished in cells pretreated with CoPP or hemin. These data suggest that the reduction of ASC was not due to the diminished gene expression of ASC or the increased secretion of ASC. Rather, the data support the idea that hemin and CoPP disrupt the inflammasome speck formation by reducing the amount of intracellular ASC.
Hemin and CoPP Inhibit NLRP3 Activation by Enhancing Autophagy
The induction of autophagy has been shown to result in the degradation of inflammasome components [12, 13] . Therefore, we next studied whether the degradation of ASC could be mediated via the induction of autophagy by hemin or CoPP. Microtubule-associated protein 1 light chain 3 (LC3) is an integral membrane protein of autophagic vesicles, which is required for the formation of autophagosomes [29] . An increased ratio of LC3-II to LC3-I has been shown to correlate with increased formation of autophagosomes [29] . In unprimed and LPS-primed human primary macrophages and THP-1 macrophages, CoPP increased the ratio of LC3-II to LC3-I in cells challenged with NLRP3 inflammasome activators ( fig. 7 a, b) .
The oligomerization of SQSTM1 precedes the autophagosome formation [30] . In THP-1 macrophages, CoPP alone induced a robust formation of SQSTM1 oligomers compared to the diffuse SQSTM1 staining in nontreated cells ( fig. 7 c) . In addition, in the presence of CoPP, ASC rather localized with nuclear DAPI-staining whereas ASC staining in nontreated cells appeared mostly cytoplasmic. SQSTM1 is degraded in the autophagosomes, and therefore the amount of intracellular SQSTM1 reflects the level of autophagosomal degradation, i.e. autophagic flux [31] . To determine the efficiency of autophagic flux, the degradation of SQSTM1 was studied in human primary macrophages. In the presence of LPS, the intracellular levels of SQSTM1 were increased compared to nonactivated cells ( fig. 7 d) . In contrast, incubation of the human primary macrophages or THP-1 macrophages in the presence of CoPP, and to a lesser extent hemin, increased the degradation of SQSTM1 both in nonactivated and activated cells ( fig. 7 d, e; online suppl. fig. 4A , B). To further study whether CoPP-or hemin-induced depletion of ASC depended on autophagy, autophagic sequestration was inhibited with 3-methyl adenine (3-MA), a phosphoinositide 3-kinase inhibitor. As expected, the treatment of the THP-1 macrophages with 3-MA for 23 h diminished the ratio of LC3-II to LC3-I (online suppl. fig. 4C ). Importantly, the treatment with 3-MA reversed the CoPP-induced depletion of intracellular ASC in both nonactivated and nigericin-activated THP-1 macrophages ( fig. 7 f; online suppl. fig. 4D ). In conclusion, the data above suggest that hemin and CoPP enhance the degradation of ASC by increasing the autophagic flux, which results in reduced intracellular ASC levels and reduced activation of the NLRP3 inflammasome.
Discussion
The activation of the NLRP3 inflammasome and the consequent secretion of IL-1β and IL-18 result in a robust inflammatory reaction, and thus stringent regulatory mechanisms of NLRP3 activation are required. In this study, we demonstrate that hemin may act as an important negative regulator of the NLRP3 inflammasome in macrophages. Pronounced inhibition of secretion of IL-1β and IL-18 was observed in the presence of hemin or its derivative CoPP. Importantly, such an inhibitory effect could also be observed in vivo. Thus, the injection of CoPP into the peritoneal cavity prior to the activation of the NLRP3 inflammasome by MSU crystals attenuated peritonitis in mice by inhibiting the secretion of IL-1β, as in the pathogenesis of gout [8] and atherosclerosis [4, 5] . Thus, the results of this study could provide a novel approach, for the treatment of not only difficult and lifethreatening autoinflammatory diseases but also more common chronic diseases, in which the activation of the NLRP3 inflammasome is involved.
